Pathological findings of hypertrophic pachymeningitis associated with eosinophilic granulomatosis with polyangiitis

Wataru Shiraishi1, Yoshitaka Tsujimoto2, Tomoko Shiraishi3

  • 1Department of Neurology, Kokura Memorial Hospital, Kitakyushu, Japan watarus@neuro.med.kyushu-u.ac.jp.

BMJ Case Reports
|September 21, 2021
PubMed

Insights

Eosinophilic granulomatosis with polyangiitis (EGPA) rarely affects the central nervous system. This study presents the first pathological findings of EGPA-associated hypertrophic pachymeningitis (HP) in a patient with neurological symptoms.

Area of Science:

  • Neurology
  • Pathology
  • Immunology

Background:

  • Eosinophilic granulomatosis with polyangiitis (EGPA), previously known as Churg-Strauss syndrome, commonly presents with neurological issues like mononeuritis multiplex.
  • Central nervous system (CNS) involvement in EGPA is infrequent, with hypertrophic pachymeningitis (HP) being exceptionally rare.

Observation:

  • A patient with EGPA experienced headache and ophthalmoplegia, leading to the diagnosis of HP.
  • A dural biopsy was performed, revealing lymphocytic inflammatory cell infiltration.

Findings:

  • The biopsy findings lacked characteristic EGPA markers such as eosinophilic infiltration, granuloma, or angiitis.
  • This represents the first reported case of EGPA-associated HP with detailed pathological examination.

Implications:

  • This case expands the understanding of CNS manifestations in EGPA.
  • Further research is needed to elucidate the specific pathological mechanisms of EGPA-associated HP.